Cargando…

An immuno-score signature of tumor immune microenvironment predicts clinical outcomes in locally advanced rectal cancer

BACKGROUND AND PURPOSE: Accumulating evidence indicates that neoadjuvant chemoradiotherapy(nCRT) success has an immune-associated constituent in locally advanced rectal cancer (LARC). The immune-associated configuration of the tumor microenvironment associated with responses to treatment was explore...

Descripción completa

Detalles Bibliográficos
Autores principales:	Xue, Zhengfa, Yang, Shuxin, Luo, Yun, He, Ming, Qiao, Huimin, Peng, Wei, Tong, Suxin, Hong, Guini, Guo, You
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9558072/ https://www.ncbi.nlm.nih.gov/pubmed/36248969 http://dx.doi.org/10.3389/fonc.2022.993726

Ejemplares similares

A 41-Gene Pair Signature for Predicting the Pathological Response of Locally Advanced Rectal Cancer to Neoadjuvant Chemoradiation
por: Xue, Zhengfa, et al.
Publicado: (2021)

MRI Radiomics Signature as a Potential Biomarker for Predicting KRAS Status in Locally Advanced Rectal Cancer Patients
por: Zhang, ZhiYuan, et al.
Publicado: (2021)

Progress in the diagnosis of lymph node metastasis in rectal cancer: a review
por: Peng, Wei, et al.
Publicado: (2023)

Predictive value of MRI-detected tumor deposits in locally advanced rectal cancer
por: Lv, Baohua, et al.
Publicado: (2023)

Multi-Omics Profiling of the Tumor Microenvironment: Paving the Way to Precision Immuno-Oncology
por: Finotello, Francesca, et al.
Publicado: (2018)

Glioblastoma Recurrence Correlates With Increased APE1 and Polarization Toward an Immuno-Suppressive Microenvironment
por: Hudson, Amanda L., et al.
Publicado: (2018)

Investigating anorectal function using postoperative MRI-based fibrosis score in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy: a two-center study
por: Yuan, Yuan, et al.
Publicado: (2023)

Immune-Stromal Score Signature: Novel Prognostic Tool of the Tumor Microenvironment in Lung Adenocarcinoma
por: Qi, Xiaoguang, et al.
Publicado: (2020)

Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
por: Kamta, Jeff, et al.
Publicado: (2017)

Prolonged neoadjuvant chemotherapy without radiation versus total neoadjuvant therapy for locally advanced rectal cancer: A propensity score matched study
por: Zhao, Xuan, et al.
Publicado: (2022)

Neoadjuvant Chemoradiotherapy Changes the Landscape of Soluble Immune Checkpoint Molecules in Patients With Locally Advanced Rectal Cancer
por: Liu, Chao, et al.
Publicado: (2022)

Tryptophan Catabolism and Response to Therapy in Locally Advanced Rectal Cancer (LARC) Patients
por: Crotti, Sara, et al.
Publicado: (2020)

The Effects of Neoadjuvant Chemoradiation in Locally Advanced Rectal Cancer—The Impact in Intratumoral Heterogeneity
por: Bettoni, Fabiana, et al.
Publicado: (2019)

The clinical relevance and prediction efficacy from therapy of tumor microenvironment related signature score in colorectal cancer
por: Jun, Xiang, et al.
Publicado: (2023)

Deep Learning Model for Predicting the Pathological Complete Response to Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
por: Lou, Xiaoying, et al.
Publicado: (2022)

Clinical Robotic Surgery Association (India Chapter) and Indian rectal cancer expert group’s practical consensus statements for surgical management of localized and locally advanced rectal cancer
por: Somashekhar, S. P., et al.
Publicado: (2022)

Prognostic value of lactate metabolism-related gene expression signature in adult primary gliomas and its impact on the tumor immune microenvironment
por: Wang, Zhihao, et al.
Publicado: (2022)

Current Status of Intensified Neo-Adjuvant Systemic Therapy in Locally Advanced Rectal Cancer
por: Engels, Benedikt, et al.
Publicado: (2012)

GLUT-1 may predict metastases and death in patients with locally advanced rectal cancer
por: Kim, Tae Hyun, et al.
Publicado: (2023)

Regional transarterial chemoembolization combined with chemoradiotherapy for locally advanced rectal cancer: a retrospective study of a new combination
por: Meng, Wen-Jun, et al.
Publicado: (2023)

A Novel Scoring System for Response of Preoperative Chemoradiotherapy in Locally Advanced Rectal Cancer Using Early-Treatment Blood Features Derived From Machine Learning
por: Kim, Jaesik, et al.
Publicado: (2021)

MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
por: Yi, Xiaoping, et al.
Publicado: (2019)

Increased Levels of Genomic Instability and Mutations in Homologous Recombination Genes in Locally Advanced Rectal Carcinomas
por: do Canto, Luisa Matos, et al.
Publicado: (2019)

Computertomography-Based Prediction of Complete Response Following Neoadjuvant Chemoradiotherapy of Locally Advanced Rectal Cancer
por: Maslova, Marina, et al.
Publicado: (2021)

Obesity may not be related to pathologic response in locally advanced rectal cancer following neoadjuvant chemoradiotherapy
por: Bao, Quoc Riccardo, et al.
Publicado: (2022)

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits
por: Zhu, Yinjie, et al.
Publicado: (2023)

Plasma Lipidomic Signature of Rectal Adenocarcinoma Reveals Potential Biomarkers
por: Fernandes Messias, Márcia Cristina, et al.
Publicado: (2018)

Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure
por: Chiloiro, Giuditta, et al.
Publicado: (2020)

Pretreatment Inflammatory-Nutritional Biomarkers Predict Responses to Neoadjuvant Chemoradiotherapy and Survival in Locally Advanced Rectal Cancer
por: Wang, Yijun, et al.
Publicado: (2021)

Exome and Tissue-Associated Microbiota as Predictive Markers of Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer
por: Takenaka, Isabella Kuniko T. M., et al.
Publicado: (2022)

MRI VS. FDG-PET for diagnosis of response to neoadjuvant therapy in patients with locally advanced rectal cancer
por: Gao, Peng Fei, et al.
Publicado: (2023)

Efficacy of concurrent radiotherapy in patients with locally advanced rectal cancer and synchronous metastasis receiving systemic therapy
por: Yin, Tzu-Chieh, et al.
Publicado: (2023)

Can lymphocytes serve as a predictor of response to preoperative chemoradiation therapy for locally advanced rectal cancer?
por: Lutsyk, Myroslav, et al.
Publicado: (2023)

Construction of an Immune-Related lncRNA Signature That Predicts Prognosis and Immune Microenvironment in Osteosarcoma Patients
por: He, Yi, et al.
Publicado: (2022)

Prognosis Analysis and Validation of m(6)A Signature and Tumor Immune Microenvironment in Glioma
por: Lin, Shaojian, et al.
Publicado: (2020)

Efficacy and tolerability of preoperative chemoradiotherapy with S-1 alone for locally advanced rectal cancer
por: Imano, Nobuki, et al.
Publicado: (2020)

Neoadjuvant short-course hyperfractionated accelerated radiotherapy (SC-HART) combined with S-1 for locally advanced rectal cancer
por: Doi, Hiroshi, et al.
Publicado: (2013)

Radiomics-Based Preoperative Prediction of Lymph Node Status Following Neoadjuvant Therapy in Locally Advanced Rectal Cancer
por: Zhou, Xuezhi, et al.
Publicado: (2020)

The Correlation Between Survival Benefit of Preoperative Radiotherapy and Pretreatment Carcinoembryonic Antigen Level in Locally Advanced Rectal Cancer
por: Wang, Lei, et al.
Publicado: (2021)

The Effect of Lymph Node Harvest on Prognosis in Locally Advanced Middle-Low Rectal Cancer After Neoadjuvant Chemoradiotherapy
por: Lin, Zhuangbin, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_lm5l8bsivtp22bkh67j4l6ubcr